Literature DB >> 19013329

End-stage renal disease and kidney transplant in HIV-infected patients.

Deirdre Sawinski1, Barbara Murphy.   

Abstract

Chronic kidney and end-stage renal disease are important complications of HIV disease and treatment. African Americans with HIV infection are at significantly increased risk for development of chronic kidney disease and for progression to end-stage renal disease. Survival of HIV-positive patients on dialysis has improved dramatically since the introduction of combination antiretroviral therapy, with hemodialysis and peritoneal dialysis appearing to offer similar survival. Renal transplant has been shown to be successful in HIV-positive patients and emerging data suggest a survival benefit over remaining on dialysis, despite data indicating an increased incidence of acute rejection. Immunosuppression dosing is complicated by interactions with antiretroviral therapy, and drug levels must be followed closely. Experience to date suggests that HIV-positive transplant recipients are best cared for in academic institutions with multi-disciplinary teams devoted to their care.

Entities:  

Mesh:

Year:  2008        PMID: 19013329     DOI: 10.1016/j.semnephrol.2008.08.002

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  4 in total

1.  Estimating the potential pool of HIV-infected deceased organ donors in the United States.

Authors:  B J Boyarsky; E C Hall; A L Singer; R A Montgomery; K A Gebo; D L Segev
Journal:  Am J Transplant       Date:  2011-03-28       Impact factor: 8.086

2.  Barriers to listing for HIV-infected patients being evaluated for kidney transplantation.

Authors:  Dong Heun Lee; Suzanne M Boyle; Gregory E Malat; Christopher Kern; Charles Milrod; Shannon DeBellis; Meera N Harhay; Karthik Ranganna; Stephen Guy; Sindhura Talluri; Tiffany Bias; Alden Doyle
Journal:  Transpl Infect Dis       Date:  2017-10-05       Impact factor: 2.228

3.  Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infection.

Authors:  Peter P Reese; Tara Tehrani; Mary Ann Lim; David A Asch; Emily A Blumberg; Maureen K Simon; Roy D Bloom; Scott D Halpern
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-25       Impact factor: 8.237

4.  Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.

Authors:  Deirdre Sawinski; Kimberly A Forde; Vincent Lo Re; David S Goldberg; Jordana B Cohen; Jayme E Locke; Roy D Bloom; Colleen Brensinger; Joe Weldon; Justine Shults; Peter P Reese
Journal:  Am J Kidney Dis       Date:  2019-01-29       Impact factor: 8.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.